SMARCA2 and prostate cancer: There are no clearly outlying points in the upper-right quadrant; the two pathways near the boundary are (i) Shen_Smarca2_targets_up, containing genes whose expression was negatively correlated with the expression of the SMARCA2 gene in prostate cancer samples, discovered in relation to androgen-induced proliferation in the prostate; and (ii) Kokkinakis_Methione_deprivation_48hr_up, which contains upregulated genes in melanoma cell-line MEWO cells after 48 hr of methionine deprivation.